financetom
Business
financetom
/
Business
/
Commerzbank on Overnight News
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Commerzbank on Overnight News
Mar 26, 2025 4:11 AM

06:32 AM EDT, 03/26/2025 (MT Newswires) -- Commerzbank in its "European Sunrise" note of Wednesday highlighted:

Markets: United States Treasuries pare gains into close, weaken further in Asia. E-minis pare gains, Asian equities mostly supported. The US dollar trades stronger, Brent recovers from the Ukraine news.

Fed: Chicago Federal Reserve Bank President Austan Goolsbee says Fed is no longer on the "golden path," sees rates "fair bit lower" in 12-18 months, but next cut may take longer than anticipated (FT).

Tariffs: President Donald Trump claims the European Union has been freeloading and is "terrible on trade," says he doesn't want too many exceptions to April 2 tariffs. Copper tariffs could be imposed within several weeks (Bloomberg sources).

U.S.: Republican party leaders say they are getting close to a plan to extend Trump's 2017 tax cuts and raise the debt ceiling. Treasury Secretary Scott Bessent says he's confident that a swift timeframe on tax cuts is achievable. Moody's warns U.S. "fiscal strength is on course for a continued multiyear decline."

Ukraine: President Volodymyr Zelensky says Ukraine will implement a partial ceasefire in the Black Sea. Russia says deal depends on sanctions relief, says it will work to implement a ban on strikes on energy infrastructure.

==EUROPE:

ECB: Governing Council (GC) member Francois Villeroy de Galhau says the European Central Bank still has room to ease policy, 2% in summer is a possible scenario. Adds that the German fiscal plan doesn't necessarily fuel prices. GC member Fabio Panetta says ECB must remain pragmatic in setting rates, says estimates of neutral rate have become 'less useful' (FT).

EU: France, Italy and Spain seek to boost military spending based on grants instead of loans (Politico).

==ASIA:

Japan: Governor Kazuo Ueda reiterates that the Bank of Japan will continue to raise rates if the economic outlook is realized.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved